Development Shaw Simon Technology 
Harvard Business Review
AUGUST 13, 2018
Recent advances in artificial intelligence (AI) and computer technology are causing us to think again about some really basic questions: what is a firm? And as computer technology simplifies and reduces transaction costs further, it is these other things that firms do uniquely well that will come more to the forefront.
Harvard Business Review
MAY 31, 2011
Biocon also sources drug molecules from other partners, especially from developing countries, such as the Cuba-based Center of Molecular Immunology (CMI). The vision and purpose of Kiran Mazumdar-Shaw , chairman and managing director of Biocon, is to deliver affordable drugs to the masses in both India and other markets.
Expert insights. Personalized for you.
9 
Let's personalize your content